THE DEAL, AT A GLANCE
From the announcementSolstice Oncology
01Who is involvedBacked by RA Capital Management, joined by Canaan Partners, ForbionFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedSolstice Oncology raised $225M Series A, announced 2026-09-10From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersSolstice Oncology's $225M Series A is an outsized Healthcare & Life Sciences capital-flow event, ranking at the 89th percentile of tracked sector rounds by size against…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Solstice Oncology · Financing Record
Explore source-linked visual explanations for Solstice Oncology. Unsupported claims are withheld while source review continues.
Record 12052 · Recorded date: 2026-09-10
Explore company records →